RE-BVS – Piemonte Repository

Sfoglia per AUTORE
LO RE G
Collezione AOU San Luigi di Orbassano

Items : 7

Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without (223)Ra. in Cancer biotherapy & radiopharmaceuticals / Cancer Biother Radiopharm. 2021 Jun;36(5):391-396. doi: 10.1089/cbr.2020.4442. Epub 2021 Mar 25.

2021
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli

De Vincentis G; De Giorgi U; Lo Re G; Cortesi E; Spada M; Salgarello M; Borsatti E; Sbrana A; Morabito A; Masini C; Zichi C; Pignata S; Fanti S; Alongi P; Donner D; Bortolus R; Alongi F; Facchini G; Tucci M; Baldari S; Costa RP; Pinto C; Galli L; Monari F; Caffo O; Frantellizzi V;

Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer. in Future oncology (London, England) / Future Oncol. 2016 Feb;12(4):493-502. doi: 10.2217/fon.15.302. Epub 2016 Jan 18.

2016
AOU San Luigi di Orbassano
ASL Torino 5

Santini D; Messina C; Perin A; Lodde M; Fratino L; Berruti A; Mucciarini C; Nicodemo M; Bonetti A; Alesini D; Zucali PA; Vicario G; Massari F; Lo Re G; Donini M; Bortolus R; Spizzo G; D'Angelo A; Zagonel V; Procopio G; Mattioli R; Mansueto G; Facchini G; Aieta M; Scognamiglio F; Ortega C; Di Lorenzo G; Caffo O; De Giorgi U; et alii...

Activity of new agents (NAs) as third-line treatment in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) after a long-term disease control (LTDC) with abiraterone acetate (AA) or enzalutamide (ENZ) post docetaxel (DOC): Preliminary results from a multicenter Italian study in Journal of Clinical Oncology

2016
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Veccia A; De Giorgi U; Facchini G; Fratino L; Gasparro D; Alesini D; Basso U; Tucci M; Ortega C; Scagliarini S; Verderame F; Lo Re G; Procopio G; Sabbatini R; Campadelli E; Zucali PA; Morelli F; Sartori D; Conteduca V; Caffo O;

Clinical outcomes in a contemporary series of "young" patients with castration-resistant prostate cancer who were 60 years and younger. in Urologic oncology / Urol Oncol. 2015 Jun;33(6):265.e15-21. doi: 10.1016/j.urolonc.2015.02.016. Epub 2015 Apr 20.

2015
AOU San Luigi di Orbassano

Caffo O; Ortega C; Di Lorenzo G; Sava T; De Giorgi U; Cavaliere C; Macrini S; Spizzo G; Aieta M; Messina C; Tucci M; Lodde M; Mansueto G; Zucali PA; Alesini D; D'Angelo A; Massari F; Morelli F; Procopio G; Ratta R; Fratino L; Lo Re G; Pegoraro MC; Zustovich F; Vicario G; Ruatta F; Federico P; La Russa F; Burgio SL; et alii...

Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study. in European urology / Eur Urol. 2015 Jul;68(1):147-53. doi: 10.1016/j.eururo.2014.10.014. Epub 2014 Oct 25.

2015
AOU San Luigi di Orbassano

Caffo O; De Giorgi U; Fratino L; Alesini D; Zagonel V; Facchini G; Gasparro D; Ortega C; Tucci M; Verderame F; Campadelli E; Lo Re G; Procopio G; Sabbatini R; Donini M; Morelli F; Sartori D; Zucali P; Carrozza F; D'Angelo A; Vicario G; Massari F; Santini D; Sava T; Messina C; Fornarini G; La Torre L; Ricotta R; Aieta M; et alii...

Activity of new agents (NAs) as third-line treatment in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) showing a primary resistance (PRes) to NAs-based second line therapy after docetaxel (DOC): Preliminary results from a multicenter Italian study in Journal of Clinical Oncology

2015
AOU San Luigi di Orbassano

Caffo O; De Giorgi U; Facchini G; Fratino L; Gasparro D; Basso U; Alesini D; Tucci M; Ortega C; Verderame F; Procopio G; Lo Re G; Campadelli E; Omarini C; Donini M; Morelli F; Zucali PA; Sartori D; Conteduca V; Galligioni E;

Activity of subsequent new drugs (NDs) in post-docetaxel (DOC) failure for metastatic castration-resistant prostate cancer (mCRPC) patients (pts): A multicenter Italian experience in Journal of Clinical Oncology

2014
AOU San Luigi di Orbassano

Caffo O; Basso U; Facchini G; Gasparro D; Alesini D; Tucci M; Ortega C; Fratino L; Campadelli E; Lo Re G; Sabbatini R; Procopio G; Zucali PA; D'Angelo A; Donini M; Massari F; Ratta R; Sava T; Messina C; De Giorgi U;